First case report of hypouricemia associated with adjuvant imatinib therapy in a patient with small intestinal gastrointestinal stromal tumor
Frontiers in Oncology · 20.05.2026 · 16
DOI: 10.3389/fonc.2026.1765401 ↗Kurz gefasst
Fallbericht in der Zeitschrift Frontiers in Oncology, online erschienen am 20.05.2026. Verfasst von Juan Bu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Research and Translational Management, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Imatinib, a tyrosine kinase inhibitor, is primarily used for the treatment of chronic myeloid leukemia and gastrointestinal stromal tumors (GIST). The most common adverse events include peripheral edema, mild nausea, vomiting, diarrhea, myalgia, muscle cramps, and skin rash. In patients with GIST receiving imatinib therapy, routine laboratory tests typically reveal hematologic abnormalities such as decreased hemoglobin, erythrocyte, neutrophil, and platelet counts, alongside elevated hepatic transaminase levels. However, to our knowledge, no cases of imatinib-associated hypouricemia have been reported. Here, we present a case of hypouricemia temporally associated with adjuvant imatinib therapy in a patient with intestinal GIST. This case highlights the importance for clinicians to be aware of hypouricemia as a potential adverse event during imatinib therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Research and Translational Management, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China.
Zitieren
APA
Bu, J., Mahan, Y., Yuemaier, R., Zhang, X., & Zhou, L. (2026). First case report of hypouricemia associated with adjuvant imatinib therapy in a patient with small intestinal gastrointestinal stromal tumor. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1765401
Vancouver
Bu J, Mahan Y, Yuemaier R, Zhang X, Zhou L. First case report of hypouricemia associated with adjuvant imatinib therapy in a patient with small intestinal gastrointestinal stromal tumor. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1765401
BibTeX
@article{Bu2026,
author = {Bu, Juan and Mahan, Yeledan and Yuemaier, Reziwanguli and Zhang, Xiaoling and Zhou, Ling},
title = {First case report of hypouricemia associated with adjuvant imatinib therapy in a patient with small intestinal gastrointestinal stromal tumor},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.1765401}
}
EUVIMED